Clinical trial
Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP (APPRAISE ATP)
NCT02923726 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP (APPRAISE ATP)
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2016
- Completion date
- July 6, 2023
- Enrollment
- 2,692 (actual)
- Sites
- 134
Conditions
As the registry lists them; a condition with its own page is linked.
sudden cardiac death